Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Investing.com - Truist Securities raised its price target on Vertex Pharmaceuticals Inc. shares (NASDAQ:VRTX) to $525 from $490 while maintaining a Buy rating. The stock currently trades at $502.89, ...

Learn about angles in trigonometry. An angle is the figure formed by two rays sharing the same endpoint. The two rays are ...

Ayurveda seems to have found a sweet spot in India’s FMCG playbook as national players turn to regional and niche brands in ...

D Systems (NYSE: DDD) today announced it has received full-scope certification under the European Union Medical Device Regulation (EU MDR) 2017/745. The certification was attained on Monday, March 17, ...

Cricket legend MS Dhoni has invested in the AI-driven storytelling platform Kuku. He will also serve as the brand ambassador of Kuku TV to promote high-quality microdramas across India and global ...

Discover how MS Dhoni's investment in Kuku is revolutionizing AI-led storytelling. Learn more about this exciting development today!

According to TipRanks.com, Chen is a 4-star analyst with an average return of 3.5% and a 47.3% success rate. Chen covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, ...

Former India captain MS Dhoni has invested in Kuku, a mobile-first storytelling platform, and will also serve as brand ...

As short-form, vernacular content gains traction, Dhoni’s bet on Kuku highlights growing investor interest in scalable, AI-driven storytelling models beyond traditional OTT platforms. MS Dhoni has ...